When comparing the biomarker levels according to gender in the COPD group, IL-6 levels were remarkably higher in females (2.31 ± 0.6) compared to male patients (1.8 ± 0.8) (P=0.008). This evidence concerns the gene IL6 and chronic obstructive pulmonary disease.